Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PROCEPT BioRobotics’ Aquablation therapy has been clinically proven to provide significant and durable symptom relief for BPH while preserving sexual function and continence across prostates of all shapes and sizes. The company’s robotic systems are commercially available with a growing installed base. Clinical studies have demonstrated safety, efficacy, and durability of results[3]. The company recently received FDA IDE approval to enroll a randomized trial comparing its surgical platform against radical prostatectomy for prostate cancer[6].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PROCEPT BioRobotics.